Specialty Pharmacy

Cancer rates significantly greater compared with non-infected individuals.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses the elements of an optimal program for monitoring patients with multiple sclerosis to ensure adherence.

Boosting immune system improves efficacy of antiretroviral drugs.

Americans are feeling more responsible for their health, with 64% indicating in a national survey that they could be making more decisions about their health and wellness.

A look back at the top stories of the week on Specialty Pharmacy Times from April 27 to May 1.

Sandoz has introduced its ready-to-use levoleucovorin injection to the US market.

Blocking production of specific immune cell protects against onset of MS.

Therapy shows promise in treatment of hepatitis C genotype-1 mono-infected patients.

When counseling patients on infertility treatment, health care providers need to perform the roles of patient advocates, researchers, educators, and confidantes, among others.

Highest uninsured rates found in patients with testicular, stomach, and cervical cancers.

Delays can negatively affect treatment efficacy and the risk of morbidity and mortality among patients.

The FDA today approved the first spray-dried fibrin sealant to be used to control bleeding during surgery.

Isavuconazonium sulfate (Cresemba) is now available to treat 2 rare yet life-threatening fungal infections.

Two new drugs showed significant reversal of disease severity.

BRAF mutations commonly found in melanoma also seen in subset of lung cancer patients.

Pharmacists can expect to answer patient questions related to HIV more often in the beginning of the week.

Merck's once-daily treatment regimen of grazoprevir and elbasvir may bring added competition to HCV drug market.

Introduction of protein to pancreatic cancer cells causes them to revert back to normal.

Gene may help identify clue to separation of overactive and underactive immune activity.

Partnership will inform and educate industry stakeholders and policymakers about the unique demands specialty medicines place on pharmacies pharmacists and patients.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses the changing role of specialty pharmacy in cancer treatment.

Nearly 30% of total biologic drug costs paid out-of-pocket.

Taking over-the-counter supplements beyond the recommended amount could increase cancer risk.

Suppression of Wnt signaling pathway shows promise.

Repeated failings to correct violations related to the manufacturing of a medical device has led the FDA to file a consent decree against Medtronic, Inc, and 2 of its officers today.

Pharmacists don't have to learn American Sign Language to effectively communicate with deaf and hard-of-hearing patients, but they do need to improve their knowledge, attitudes, and comfort levels.

Despite increases in liver cirrhosis hospitalizations over the years, the cirrhotic inpatient death rate has dropped 41%.

Long term implications result when patients stop taking disease-modifying drugs.

An antiviral and anti-cancer drug combination was 100% effective in preclinical trials.

Top stories of the week on Specialty Pharmacy Times from April 20 to April 24.